42
Participants
Start Date
October 20, 2010
Primary Completion Date
August 14, 2011
Study Completion Date
August 14, 2011
Solifenacin succinate suspension 2.5 mg
Adolescents and children are given a single dose of solifenacin succinate liquid suspension orally via syringe in the morning of day 1 followed by a glass of water. Doses are calculated per weight of the participant, targeting to have equivalent doses of 2.5 mg of solifenacin once daily in adults.
Solifenacin succinate suspension 5 mg
Adolescents and children are given a single dose of solifenacin succinate liquid suspension orally via syringe in the morning of day 1 followed by a glass of water. Doses are calculated per weight of the participant, targeting to have equivalent doses of 5 mg dose of solifenacin once daily in adults.
Solifenacin succinate suspension 10 mg
Adolescents and children are given a single dose of solifenacin succinate liquid suspension orally via syringe in the morning of day 1 followed by a glass of water. Doses are calculated per weight of the participant, targeting to have equivalent doses 10 mg dose of solifenacin once daily in adults.
Aarhus
Kortrijk
Ghent
Gothenburg
Uppsala
Cambridge
Manchester
Sheffield
Lead Sponsor
Astellas Pharma Inc
INDUSTRY